8,700 Studies Reviewed. 87.0% Found Biological Effects. The Evidence is Clear.
Shield Your Body
Whole Body / General

Hosseini E, Kianifard D

Bioeffects Seen

Authors not listed · 2023

Share:

Just a few bacterial strains can dominate gut health, showing how sensitive biological systems are to environmental disruption.

Plain English Summary

Summary written for general audiences

Researchers studied 483 people with digestive symptoms to better understand small intestinal bacterial overgrowth (SIBO), a condition where harmful bacteria multiply in the small intestine. They found that specific bacterial strains, particularly E. coli and Klebsiella, dominate the gut microbiome in SIBO patients and correlate directly with symptoms like abdominal pain, diarrhea, and bloating. The study confirms that a bacterial count of 10³ CFU/mL is the optimal threshold for diagnosing SIBO.

Why This Matters

While this study focuses on digestive health rather than EMF exposure, it reveals something crucial about how our bodies respond to environmental stressors. The research shows that when our internal ecosystem becomes disrupted, just a few dominant bacterial strains can overwhelm the system and create widespread symptoms. This mirrors what we see with EMF exposure - small changes in our cellular environment can cascade into significant health effects. The study's finding that specific metabolic pathways for hydrogen and hydrogen sulfide production become enhanced in SIBO patients is particularly relevant, as these same pathways can be influenced by electromagnetic fields. What this research demonstrates is how sensitive our biological systems are to disruption, whether from bacterial overgrowth or electromagnetic radiation.

Exposure Information

Specific exposure levels were not quantified in this study.

Cite This Study
Unknown (2023). Hosseini E, Kianifard D.
Show BibTeX
@article{hosseini_e_kianifard_d_ce4405,
  author = {Unknown},
  title = {Hosseini E, Kianifard D},
  year = {2023},
  doi = {10.1016/j.cgh.2023.06.001},
  
}
DOI: 10.1016/j.cgh.2023.06.001PubMed: 37315761

Quick Questions About This Study

The study confirms that ≥10³ CFU/mL (colony forming units per milliliter) is the optimal threshold for diagnosing SIBO. This count correlates with decreased microbial diversity, network disruption, and gastrointestinal symptoms like abdominal pain and bloating.
Two main E. coli strains and two Klebsiella species represent 40.24% of all duodenal bacteria in SIBO patients. These few bacterial strains overwhelm the normal diverse microbiome and correlate directly with symptom severity.
Duodenal microbial diversity progressively decreases as bacterial counts increase. Patients with ≥10³ CFU/mL show significantly reduced microbial network connectivity, with harmful bacteria like Escherichia and Klebsiella becoming dominant.
Microbial pathways for carbohydrate fermentation, hydrogen production, and hydrogen sulfide production become enhanced in SIBO patients. These metabolic changes correlate directly with gastrointestinal symptoms and represent disrupted normal digestive processes.
Researchers analyzed 483 subjects undergoing upper endoscopy procedures. Of these, 385 had normal bacterial counts (<10³ CFU/mL) while 98 had elevated counts indicating SIBO, with varying severity levels.